Register today for the SciBX Summit on Innovation in Drug Discovery & Development

Join key stakeholders from academia, biotech, pharma and the investment community to create a roadmap for solving key translational issues in important emerging areas of drug discovery and development. This year's summit will focus on four areas where recent progress is rapidly changing the translational playing field: non-coding RNAs, chimeric antigen receptor-based cell therapies, new models in neurodegenerative disease and emerging targets in epigenetics. Panel topics to be presented are: Non-coding RNAs as tools and targets New models in neurodegenerative disease CAR-based cellular therapies Epigenetics' second wind Organizers: Gaspar Taroncher-Oldenburg (SciBX, Nature Publishing Group, USA) Karen Bernstein (SciBX , BioCentury, USA) Steven Edelson (SciBX, BioCentury, USA) When October 29-30, 2013 Where The Colonnade Hotel Boston, MA, USA Advisory Council

For more information and to register, visit: www.nature.com/natureconferences/sidds13

Twitter